Cancer Immune Therapy: Prognostic Significance and Implications for Therapy of PD-1 in BCG-Relapsing Bladder Cancer

Neelam Mukherjee; Robert Svatek

doi:10.1245/s10434-018-6610-7

Cancer Immune Therapy: Prognostic Significance and Implications for Therapy of PD-1 in BCG-Relapsing Bladder Cancer

Department of Urology

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	2498-2499
Number of pages	2
Journal	Annals of Surgical Oncology
Volume	25
Issue number	9
DOIs	https://doi.org/10.1245/s10434-018-6610-7
State	Published - Sep 1 2018

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1245/s10434-018-6610-7

Cite this

@article{0bd20166ef6a44d68eb59926b3acafc6,

title = "Cancer Immune Therapy: Prognostic Significance and Implications for Therapy of PD-1 in BCG-Relapsing Bladder Cancer",

author = "Neelam Mukherjee and Robert Svatek",

year = "2018",

month = sep,

day = "1",

doi = "10.1245/s10434-018-6610-7",

language = "English (US)",

volume = "25",

pages = "2498--2499",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "9",

}

TY - JOUR

T1 - Cancer Immune Therapy

T2 - Prognostic Significance and Implications for Therapy of PD-1 in BCG-Relapsing Bladder Cancer

AU - Mukherjee, Neelam

AU - Svatek, Robert

PY - 2018/9/1

Y1 - 2018/9/1

UR - https://www.scopus.com/pages/publications/85049552337

UR - https://www.scopus.com/pages/publications/85049552337#tab=citedBy

U2 - 10.1245/s10434-018-6610-7

DO - 10.1245/s10434-018-6610-7

M3 - Editorial

C2 - 29971674

AN - SCOPUS:85049552337

SN - 1068-9265

VL - 25

SP - 2498

EP - 2499

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

IS - 9

ER -

Cancer Immune Therapy: Prognostic Significance and Implications for Therapy of PD-1 in BCG-Relapsing Bladder Cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this